Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
LAUNCHPAD
Second Extension - Granted
Show more
Class 40: custom manufacturing of biopharmaceutical preparations for cell therapy
Class 42: Testing, research, and development of biopharmaceutical preparations for cell therapy; Scientific services, namely, testing, scientific research and development in the field of processes for cell therapy; scientific research services, clinical research, and pre-clinical research in the field of cell therapy; consulting services in the fields of biopharmaceutical research and development and genetic science
Class 40 – Materials treatmentClass 42 – Technology & SaaS
Status timeline
- 6 May 2024Application filedNew Application Entered
- 25 Aug 2024Assigned to an examining attorneyAssigned To Examiner
- 26 Sep 2024Response to office action filedTeas Response To Office Action Received
- 20 Mar 2025Approved for publicationApproved For Pub - Principal Register
- 15 Apr 2025Published for oppositionPublished For Opposition
- 10 Jun 2025Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 18 Nov 2025Statement-of-use extension 1 grantedSou Extension 1 Granted
- 29 May 2026Statement-of-use extension 2 grantedSou Extension 2 Granted
All 24 events
| 2026-05-30 | Notice Of Approval Of Extension Request E-Mailed |
| 2026-05-29 | Sou Teas Extension Received |
| 2026-05-29 | Sou Extension 2 Filed |
| 2026-05-29 | Sou Extension 2 Granted |
| 2025-11-19 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-11-18 | Sou Teas Extension Received |
| 2025-11-18 | Sou Extension 1 Filed |
| 2025-11-18 | Sou Extension 1 Granted |
| 2025-06-10 | Noa Mailed - Sou Required From Applicant |
| 2025-04-15 | Published For Opposition |
| 2025-04-15 | Official Gazette Publication Confirmation E-Mailed |
| 2025-04-09 | Notification Of Notice Of Publication E-Mailed |
| 2025-03-24 | Law Office Publication Review Completed |
| 2025-03-20 | Approved For Pub - Principal Register |
| 2024-11-22 | Assigned To Lie |
| 2024-11-22 | Combined Examiner's Amendment/Priority Action Entered |
| 2024-09-26 | Teas Response To Office Action Received |
| 2024-08-30 | Examiners Amendment And/Or Priority Action - Completed |
| 2024-08-30 | Combined Examiner's Amendment/Priority Action Automatic Entry |
| 2024-08-30 | Examiner's Amendment/Priority Action E-Mailed |
| 2024-08-30 | Notification Of Examiner's Amendment/Priority Action E-Mailed |
| 2024-08-25 | Assigned To Examiner |
| 2024-05-06 | New Application Entered |
| 2024-05-06 | New Application Office Supplied Data Entered |
Goods & services by class
Class 40 Materials treatment
custom manufacturing of biopharmaceutical preparations for cell therapy
Class 42 Technology & SaaS
Testing, research, and development of biopharmaceutical preparations for cell therapy; Scientific services, namely, testing, scientific research and development in the field of processes for cell therapy; scientific research services, clinical research, and pre-clinical research in the field of cell therapy; consulting services in the fields of biopharmaceutical research and development and genetic science
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 31 May 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.